orio pharma logo

LAPANIX 250 MG

5/5

LAPANIX 250 MG

LAPANIX

250 MG

Lapatinib

Beacon Pharmaceuticals Ltd.

Product Description:

Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase domains of both EGFR (ErbB1) and of HER2 (ErbB2) receptors. Lapatinib retained significant activity against HER2-amplified breast cancer cell lines selected for long-term growth in trastuzumab-containing medium in vitro and was synergistic in combination with trastuzumab in these cell lines.

Product Features:

Product Name:Lapanix
Generic Name:Lapatinib
Formulation:Tablet
Available Pack Size:150’s Pot
Available Strength:250 mg